Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Milestones in Parkinson's disease—Clinical and pathologic features

Halliday, Glenda, Lees, Andrew, Stern, Matthew·2011·Movement Disorders

Abstract

The identification of the widespread deposition of fibrillized α‐synuclein in Lewy bodies and Lewy neurites in the brains of patients with Parkinson's disease in 1997 has had a profound impact on how the disease is now conceptualized. The previous focus on the loss of the dopaminergic nigrostriatal system, the concept of subcortical dementia, and the idea that Parkinson's disease was dominated by motor impairment have all given way to research assessing more diverse brain regions, clinical symptoms, and phenotypes. It is now recognized that Parkinson's disease is more than just a loss of midbrain dopaminergic neurons in association with Lewy bodies. There are now several theories on how the disease develops and progresses currently being validated in a variety of studies, although many of these theories have yet to incorporate the phenotypic clinical and pathological changes associated with age. A particularly exciting new area of research involves the cell‐to‐cell transmission of pathogenic proteins. The recent consensus definition of Parkinson's disease dementia will allow its pathologic substrates to be determined. These advances have progressed to a stage where the preclinical stages of Parkinson's disease and its specific signs and symptoms are being predicted and tested clinically. Such strategies herald a future wave of preventive strategies for Parkinson's disease and its clinical symptoms. © 2011 Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.23669

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 72

  1. Parkinson J, 1817, Essay on the Shaking Palsy
  2. 10.1002/mds.870040514 · DOI · Paper page
  3. 10.1001/archneur.1984.04050190080019 · DOI · Paper page
  4. Kosaka K, 1988, Lewy body disease with and without dementia: a clinicopathological study of 35 cases, Clin Neuropathol, 7, 299
  5. Braak H, 1995, Nigral and extranigral pathology in Parkinson's disease, J Neural Transm Suppl, 46, 15
  6. Double KL, 1996, Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease, Dementia, 7, 304
  7. 10.1002/mds.22867 · DOI
  8. 10.1093/brain/114.5.2283 · DOI · Paper page
  9. 10.1002/mds.10258 · DOI
  10. 10.1002/1531-8249(200003)47:3<345::AID-ANA10>3.0.CO;2-V · doi:10.1002/1531-8249(200003)47:3<345::aid-ana10>3.0.co;2-v
  11. 10.1006/exnr.1997.6418 · DOI
  12. Bohnen NI, 2010, The cholinergic system and Parkinson disease, Behav Brain Res
  13. 10.1093/brain/awm097 · DOI · Paper page
  14. 10.1002/ana.410270405 · DOI · Paper page
  15. 10.1093/brain/awf251 · DOI · Paper page
  16. 10.1002/mds.23305 · DOI
  17. 10.1093/brain/118.1.131 · DOI
  18. 10.1002/mds.20289 · DOI
  19. 10.1016/S0166-2236(03)00038-9 · DOI · Paper page
  20. 10.1002/mds.21065 · DOI · Paper page
  21. Wakabayashi K, 1993, [Incidental occurrence of Lewy bodies in the brains of elderly patients—the relevance to aging and Parkinson's disease], No To Shinkei, 45, 1033
  22. 10.1212/WNL.52.6.1269 · DOI · Paper page
  23. 10.1111/j.1468-1331.2008.02056.x · DOI · Paper page
  24. 10.1002/mds.22672 · DOI · Paper page
  25. 10.1038/nrn2477 · DOI · Paper page
  26. 10.1007/s00401-008-0344-8 · DOI · Paper page
  27. 10.1007/s00401-008-0345-7 · DOI · Paper page
  28. 10.1002/mds.22637 · DOI
  29. 10.1111/j.1365-2990.2007.00923.x · DOI · Paper page
  30. 10.1111/j.1365-2990.2008.00937.x · DOI
  31. 10.1111/j.1749-6632.2009.05118.x · DOI · Paper page
  32. 10.1002/ana.21541 · DOI · Paper page
  33. 10.1111/j.1750-3639.2007.00117.x · DOI
  34. 10.1016/0021-9681(75)90058-2 · DOI · Paper page
  35. 10.1002/mds.870100309 · DOI · Paper page
  36. 10.1159/000109757 · DOI
  37. 10.1288/00005537-198402000-00004 · DOI · Paper page
  38. 10.1212/WNL.38.8.1237 · DOI · Paper page
  39. 10.1212/WNL.43.5.962 · DOI
  40. 10.1093/jnen/61.5.413 · DOI · Paper page
  41. 10.1002/mds.21560 · DOI · Paper page
  42. 10.1007/BF02292766 · DOI
  43. 10.1093/brain/awm302 · DOI · Paper page
  44. 10.1002/mds.21989 · DOI · Paper page
  45. 10.1111/j.1440-1827.2004.01680.x · DOI
  46. 10.1111/j.1750-3639.2006.00032.x · DOI · Paper page
  47. 10.1002/mds.23348 · DOI
  48. 10.1002/mds.23347 · DOI
  49. 10.1002/mds.22757 · DOI
  50. 10.1212/WNL.0b013e3181ca0166 · DOI · Paper page
  51. 10.1212/WNL.45.4.709 · DOI · Paper page
  52. 10.1212/WNL.55.11.1730 · DOI
  53. 10.1093/brain/awm056 · DOI · Paper page
  54. 10.1093/brain/awm142 · DOI · Paper page
  55. 10.1093/brain/awq059 · DOI · Paper page
  56. 10.1093/jnen/62.4.363 · DOI
  57. 10.1093/jnen/64.2.156 · DOI · Paper page
  58. 10.1212/01.wnl.0000306697.48738.b6 · DOI · Paper page
  59. 10.1001/archneur.63.4.584 · DOI · Paper page
  60. 10.1212/01.WNL.0000065889.42856.F2 · DOI · Paper page
  61. 10.1212/01.wnl.0000266626.64913.0f · DOI
  62. 10.1111/j.1750-3639.2000.tb00269.x · DOI · Paper page
  63. 10.1212/01.WNL.0000158422.41380.82 · DOI · Paper page
  64. 10.1212/WNL.43.9.1690 · DOI
  65. 10.1212/WNL.54.8.1596 · DOI · Paper page
  66. 10.1016/j.jns.2009.08.034 · DOI · Paper page
  67. Jellinger KA, 2000, Morphological substrates of mental dysfunction in Lewy body disease: an update, J Neural Transm Suppl, 59, 185
  68. 10.1007/s00401-009-0597-x · DOI
  69. 10.1111/j.1750-3639.2009.00371.x · DOI
  70. Harding AJ, 2001, Cortical Lewy body pathology in the diagnosis of dementia, Acta Neuropathol (Berl), 102, 355, 10.1007/s004010100390 · DOI · Paper page
  71. 10.1001/archneur.59.1.102 · DOI · Paper page
  72. 10.1002/mds.22719 · DOI

Cited by

See all 196

Metadata

Authors
Halliday, G., Lees, A., & Stern, M.
Venue
Movement Disorders
Publisher
Wiley
Published
2011-05
Volume
26
Issue
6
Pages
1015-1021
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2129848302
Cited by
196
References
15
FWCI
10.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.